• You are now in...
  • Global

Ropes & Gray LLP

Boston

  • Prudential Tower
  • 800 Boylston Street
  • Boston
  • Massachusetts
  • USA
  • MA 02199-3600
  • Tel:+1 617 951 7000
  • Fax:+1 617 951 7050
  • Email:Contact Us
  • Web:
  • Chairman: R Bradford Malt
  • Managing Partner: David C Chapin
  • Number of partners: 300
  • Number of lawyers: 1000

Firm Overview: Ropes & Gray is one of the world’s most highly respected law firms, with offices in key business and financial capitals in Asia, Europe and North America. The firm’s network of over 1,000 lawyers and professionals provides the highest quality legal advice for clients’ most critical legal and business issues.

Main Areas of Practice:  

Private Equity:
■ TPG Capital: $1.9b acquisition of Par Pharmaceutical Companies, acquisition of Eze Castle Software
■ Bain Capital: $3b acquisition of Skylark; $1b acquisition of a minority interest in Genpact; acquisition of 50 percent of Jupiter Shop Channel
■ Berkshire Partners: $2b acquisition of Lightower & Sidera Networks
■ Blackstone Group: $3b acquisition of Emdeon; $680m acquisition of Pactera Technology
■ Madison Dearborn: $1.3b acquisition of National Financial Partners
■ H.I.G.: $519m acquisition of Caraustar Industries

M&A:
■ Alexion Pharmaceuticals: $1.08b acquisition of Enobia Pharma
■ Special Committee of Cole Credit Property Trust: $7.1b acquisition of Spirit Realty Capital, Inc.
■ Cubist Pharmaceuticals: $1.4b simultaneous acquisitions of Optimer Pharma and Trius Therapeutics
■ State Street: $550m acquisition of Goldman Sachs Administration Services
■ Party City: $2.64b sale to THL
■ Liberty Global: $24b acquisition of Virgin Media
■ Wright Medical: $290m sale of OrthoRecon Business
■ China Everbright: $3.7b acquisition of Focus

Media Finance:
■ Liberty Global: Financing for $23.3b acquisition of Virgin Media; €3.16b acquisition of Kabel BW Erste Beteiligungs GmbH
■ TPG Capital: Financing for $175m take-private acquisition of ShangPharma Corporation; $1.695b acquisition of Par Pharmaceutical
■ Bain Capital: Financing for $3.3b acquisition of Skylark; $1.25b acquisition of MYOB; $1.445b acquisition of The Gymboree Corporation
■ Highbridge Capital (among others): Financing for €1.8b acquisition of BSN Medical
■ Dunkin’ Brands: Financing for $1.975b ‘whole business securitisation’ and funding of shareholder dividend

Business Restructuring:
■ Committee of mezzanine lenders to KCA Deutag Oil Services Group (KCA), including funds managed by BlackRock, EIG and GoldenTree, in connection with KCA’s financial restructuring

Investment Management:
■ Significant industry participants, incl. Allianz, Ameriprise, BlackRock, DWS, MFS, Natixis, PIMCO, Putnam
■ Start-ups, including DoubleLine Funds and Stone Harbor Funds, two of the fastest-growing mutual fund complexes
■ ETFs and their sponsors, including ProShares
■ BlackRock (acquisition of Swiss Re’s fund of funds business), Natixis (acquisition of McDonnell Investment Management), HighMark Funds (sale of assets to Reich & Tang and Nationwide Funds), SteelPath Fund Advisors (sale to Oppenheimer Funds), H.I.G. Capital (acquisition of Arctic Glacier Income Fund), DST Systems (acquisition of ALPS Fund Services)

Hedge Funds:
■ PIMCO: formation of numerous hedge funds, including various tail risk funds and several overlay strategy programs, and related separate account products
■ Blackstone: formation of a hybrid private equity/hedge fund vehicle that seeds third-party hedge fund managers
■ UBS: structuring of open-end real estate funds of funds and investments by those funds
■ GMO: offering and operation of various onshore and offshore hedge funds, including equity, fixed income, currency and asset allocation funds
■ Schroders: organisation of onshore and offshore hedge funds and advice regarding offering global investment products in the United States

Private Investment Funds:
■ Represent fund sponsors in fundraising, general sponsor and regulatory matters. Bain Capital, TPG Capital, PIMCO, Nordic Capital, RRJ Capital, CITIC Private Equity and others
■ Represent institutional investors in fund investment projects. AlpInvest, Temasek, Harvard and Stanford Universities, Makena Capital Management, sovereign wealth funds and others In last 6 years acted as counsel:
■ to organise 500+ separate funds of all types, including buyouts, real estate, energy, credit, macro, quantitative strategies, fund of funds and venture capital
■ for 100+ investors in connection with investments in approximately 2,250 private funds

Life Sciences:
■ Mitsubishi Tanabe Pharma: $357m acquisition of 60 percent interest in Medicago from Philip Morris
■ Biogen: $3.25b in acquisition of Elan’s interest in TYSABRI
■ Johnson & Johnson: $650m acquisition of Aragon

Pharmaceuticals Intellectual Property:
■ SAP: Achieved victory in first-ever covered business method review trial before PTAB
■ Purdue: Secured successful decision marking end of 14 years of litigation relating to OxyContin® product
■ AstraZeneca PLC: Routinely provide IP due diligence support on international licensing and acquisition opportunities, as well support on complex patent matters
■ Zynga: Negotiation of strategic relationship with Hasbro to extend Zynga’s virtual game success to traditional board games and toys
■ Rovi: Prosecute Rovi’s worldwide patent and trademark portfolio, and perform due diligences on target portfolios considered for acquiring or licensing

Government Enforcement/FCPA:
■ Secured dismissal of all 13 felony charges against Stryker Biotech following opening statements in exchange for a fine and a plea to a single misdemeanor, and helped secure dismissal of all charges against the former company president and three sales directors in a trial involving alleged off-label marketing
■ Represented a global medical device company in connection with a DOJ and SEC industry-wide FCPA investigation and secured a deferred prosecution agreement with the SEC, settling the government’s charges

Litigation:
■ Sony: global coordinating counsel for litigation, including 65 putative class actions, and government investigations related to criminal cyberattacks
■ Carter’s Inc.: secured first non-prosecution agreement with SEC; won dismissal without prejudice of two securities fraud class actions claims with aggregate exposure of nearly $500m
■ Goldman Sachs: secured jury verdict in favour of Goldman following a five-week trial in which the plaintiff claimed $1b in damages. The founders and majority shareholders of the speech recognition company Dragon Systems, Inc. brought the case against Goldman for its role as financial advisor to Dragon in its all-stock sale to Lernout & Hauspie in 2000.

Areas of Practice

  • Antitrust
  • Business Restructuring
  • Business & Securities Litigation
  • Finance
  • Government Enforcement/FCPA
  • Health Care
  • Hedge Funds
  • Intellectual Property
  • Investment Management
  • Life Sciences
  • M&A
  • Private Equity
  • Real Estate
  • Tax & Benefits

Branches

  • 191 North Wacker Drive,
  • 32nd Floor,
  • Chicago,
  • Illinois
  • USA
  • IL 60606
  • Tel +1 312 845 1200
  • Fax +1 312 845 5500
  • 1211 Avenue of the Americas,
  • New York,
  • USA
  • NY 10036-8704
  • Tel +1 212 596 9000
  • Fax +1 212 596 9090
  • Three Embarcadero Center,
  • San Francisco,
  • California
  • USA
  • CA 94111-4006
  • Tel +1 415 315 6300
  • Fax +1 415 315 6350
  • 1900 University Avenue,
  • 6th Floor,
  • East Palo Alto,
  • California
  • USA
  • CA 94303-2284
  • Tel +1 650 617 4000
  • Fax +1 650 617 4090
  • One Metro Center 700 12th Street NW,
  • Suite 900,
  • Washington, DC,
  • District of Columbia
  • USA
  • 20005-3948
  • Tel +1 202 508 4600
  • Fax +1 202 508 4650
  • 41st Floor, One Exchange Square,
  • 8 Connaught Place,
  • Central,
  • Hong Kong,
  • China
  • Tel +11 852 3664 6488
  • Fax +11 852 3664 6588
  • 5 New Street Square,
  • 5th Floor,
  • London,
  • Greater London
  • UK
  • EC4A 3BF
  • Tel (020) 3122 1100
  • Fax (020) 3122 1101
  • Email : londoninfo@ropesgray.com
  • Yusen Building 2F ,
  • 3-2 Marunouchi 2-Chome,
  • Chiyoda-ku,
  • Tokyo,
  • Tokyo-to
  • Japan
  • 100-0005
  • Tel +81 3 6259 3500
  • Fax +81 3 6259 3501
  • 36F, Park Place,
  • 1601 Nanjing Road West,
  • Shanghai,
  • China
  • 200040
  • Tel +86 21 6157 5200
  • Fax +86 21 6157 5299
  • POSCO P&S Tower, 21F ,
  • 134 Teheran-ro, Gangnam-gu ,
  • Seoul,
  • South Korea
  • 135-923
  • Tel T +82 2 2141 5900
  • Fax +82 2 2141 5950